Fisher C E, Sutherland J A, Krause J E, Murphy J R, Leeman S E, vanderSpek J C
Evans Department of Clinical Research, Boston University Medical Center Hospital, Boston, MA 02118, USA.
Proc Natl Acad Sci U S A. 1996 Jul 9;93(14):7341-5. doi: 10.1073/pnas.93.14.7341.
We have genetically replaced the native receptor binding domain of diphtheria toxin with an extended form of substance P (SP): SP-glycine (SP-Gly). The resulting fusion protein, DAB389SP-Gly, is composed of the catalytic and transmembrane domains of diphtheria toxin genetically coupled to SP-Gly. Because native SP requires a C-terminal amide moiety to bind with high affinity to the SP receptor, the precursor form of the fusion toxin, DAB389SP-Gly, was converted to DAB389SP by treatment with peptidylglycine-alpha-amidating monooxygenase. We demonstrate that following conversion, DAB389SP is selectively cytotoxic for cell lines that express either the rat or the human SP receptor. We also demonstrate that the cytotoxic action of DAB389SP is mediated via the SP receptor and dependent upon passage through an acidic compartment. To our knowledge, this is the first reported use of a neuropeptide as the targeting ligand for a fusion toxin; and the first instance in which an inactive precursor form of a fusion toxin is converted to the active form by a posttranslational modification.
我们已通过基因手段将白喉毒素的天然受体结合结构域替换为一种延长形式的P物质(SP):SP-甘氨酸(SP-Gly)。由此产生的融合蛋白DAB389SP-Gly由白喉毒素的催化结构域和跨膜结构域与SP-Gly基因偶联而成。由于天然SP需要C末端酰胺基团才能与SP受体高亲和力结合,融合毒素的前体形式DAB389SP-Gly经肽基甘氨酸α-酰胺化单加氧酶处理后转化为DAB389SP。我们证明,转化后,DAB389SP对表达大鼠或人SP受体的细胞系具有选择性细胞毒性。我们还证明,DAB389SP的细胞毒性作用是通过SP受体介导的,并且依赖于通过酸性区室。据我们所知,这是首次报道使用神经肽作为融合毒素的靶向配体;也是首次通过翻译后修饰将融合毒素的无活性前体形式转化为活性形式的实例。